The generic version of China Health Related Outcomes Measures (CHROME-G): psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population

被引:0
作者
Xie, Shitong [1 ,2 ]
Wu, Jing [1 ,2 ]
Chen, Pinan [1 ,2 ]
He, Xiaoning [1 ,2 ]
Zhao, Kun [3 ]
Xie, Feng [4 ,5 ]
机构
[1] Tianjin Univ, Fac Med, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
[2] Tianjin Univ, Ctr Social Sci Survey & Data, Tianjin, Peoples R China
[3] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[5] McMaster Univ, Ctr Hlth Econ & Policy Anal, Hamilton, ON, Canada
基金
中国国家自然科学基金;
关键词
CHROME-G; Psychometric property; EQ-5D-5L; SF-6Dv2; Health-related quality of life; VALUE SET; EAST;
D O I
10.1186/s12889-024-20999-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectivesThe CHROME-G is the first generic preference-based measure developed in China. This study aimed to validate and compare the psychometric properties of the CHROME-G with the EQ-5D-5L and SF-6Dv2 among the Chinese general population.MethodsA representative sample of the Chinese general population in terms of age, gender, education, and urban/rural residence was recruited for an online survey. During the survey, respondents completed three instruments (first the CHROME-G, then the EQ-5D-5L and SF-6Dv2 in random order), demographic and health-related questions. The retest survey was carried out after two weeks. Ceiling/floor effects were first assessed. Convergent and divergent validity was examined using Spearman's rank correlation. Known-group validity was examined using the non-parametric Kruskal-Wallis H test and effect size. Test-retest reliability was assessed using the intraclass correlation coefficient and weighted Kappa statistics.ResultsOne thousand respondents (51.1% male, mean age 44.7 years) completed the first survey, with 378 also completing the retest survey. The mean +/- SD completion time was 2.03 +/- 0.58 min for the CHROME-G, and 1.37 +/- 0.54 and 1.13 +/- 0.38 min for the EQ-5D-5L and SF-6Dv2. Only the EQ-5D-5L had a ceiling effect of 35.1%. The range of Spearman rank's correlations was 0.45-0.62 for convergent validity and 0.14-0.46 for divergent validity. Among different health subgroups, the effect size for the CHROME-G, EQ-5D-5L and SF-6Dv2 was 1.348-3.416, 1.362-3.325 and 1.097-2.228, respectively. The ICC for test-retest was 0.791 for the CHROME-G, compared with 0.994 and 0.971 for the EQ-5D-5L and SF-6Dv2.ConclusionsThe CHROME-G showed good and comparable psychometric properties with the EQ-5D-5L and SF-6Dv2.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures [J].
Anthoine E. ;
Moret L. ;
Regnault A. ;
Sbille V. ;
Hardouin J.-B. .
Health and Quality of Life Outcomes, 12 (1)
[2]   Sample size requirements for estimating intraclass correlations with desired precision [J].
Bonett, DG .
STATISTICS IN MEDICINE, 2002, 21 (09) :1331-1335
[3]   A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models [J].
Brazier, John ;
Ara, Roberta ;
Rowen, Donna ;
Chevrou-Severac, Helene .
PHARMACOECONOMICS, 2017, 35 :S21-S31
[4]   Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2 [J].
Brazier, John E. ;
Mulhern, Brendan J. ;
Bjorner, Jakob B. ;
Gandek, Barbara ;
Rowen, Donna ;
Alonso, Jordi ;
Vilagut, Gemma ;
Ware, John E. .
MEDICAL CARE, 2020, 58 (06) :557-565
[5]   Overview of Classical Test Theory and Item Response Theory for the Quantitative Assessment of Items in Developing Patient-Reported Outcomes Measures Comment [J].
Cappelleri, Joseph C. ;
Lundy, J. Jason ;
Hays, Ron D. .
CLINICAL THERAPEUTICS, 2014, 36 (05) :648-662
[6]   Comparing health-related quality of life of Dutch and Chinese patients with traumatic brain injury: do cultural differences play a role? [J].
Cnossen, Maryse C. ;
Polinder, Suzanne ;
Vos, Pieter E. ;
Lingsma, Hester F. ;
Steyerberg, Ewout W. ;
Sun, Yanming ;
Ye, Pengpeng ;
Duan, Leilei ;
Haagsma, Juanita A. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
[7]  
Gao J, 2023, Chin Gen Pract, P1
[8]   Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) [J].
Herdman, M. ;
Gudex, C. ;
Lloyd, A. ;
Janssen, M. F. ;
Kind, P. ;
Parkin, D. ;
Bonsel, G. ;
Badia, X. .
QUALITY OF LIFE RESEARCH, 2011, 20 (10) :1727-1736
[9]   A Systematic Review of Health Care Efficiency Measures [J].
Hussey, Peter S. ;
de Vries, Han ;
Romley, John ;
Wang, Margaret C. ;
Chen, Susan S. ;
Shekelle, Paul G. ;
McGlynn, Elizabeth A. .
HEALTH SERVICES RESEARCH, 2009, 44 (03) :784-805
[10]   An analysis of the complementarity of ICECAP-A and EQ-5D-3 L in an adult population of patients with knee pain [J].
Keeley, T. ;
Coast, J. ;
Nicholls, E. ;
Foster, N. E. ;
Jowett, S. ;
Al-Janabi, H. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14